TRAX

First Tracks Biotherapeutics, Inc. Ordinary Shares When-Issued

NASDAQ: TRAXV · HEALTHCARE · BIOTECHNOLOGY

$22.51

+0.00% today

Updated 2026-07-29

Market cap

$782.20M

P/E ratio

—

P/S ratio

—

EPS (TTM)

$—

Dividend yield

—

52W range

$15 – $27

Volume

0.0M

Market cap

$782.20M

P/E ratio

—

P/S ratio

—

EPS (TTM)

$—

Dividend yield

—

52W range

$15 – $27

Volume

0.0M

WallStSmart proprietary scores

out of 100

Grade: F

Strong Sell

Investment rating

4.3

Growth

6.0

Quality

3.5

Profitability

5.0

Valuation

C+

2/9

Piotroski F-Score

Weak

—

Altman Z-Score

—

Industry rank

—

View all highly rated stocks (75+) →206 stocks currently score above 75

Price targets

Analyst target

—

12-Month target

—

Intrinsic (DCF)

—

Margin of safety

—

Price chart

Stock snapshot

Strengths

Insufficient data

Risks

- Piotroski 2/9 — weak financial health

- Thin margins at 0.00%

- Negative free cash flow $-32.58M

Key financials

Revenue Net Income Free Cash Flow

Metric	2023	2024	TTM
Revenue	$0.00	$0.00	$0.00
Net income	$-106.15M	$-163.71M	$-50.48M
EPS	—	—	$—
Free cash flow	$-93.81M	$-126.16M	$-32.58M
Profit margin	—	—	—

Peer comparison

Company	Mkt Cap	Score	Growth	Profit	Value	Quality	MoS	Rating
TRAXV	$782.20M	23	4.3	3.5	5.0	6.0	—	Avoid
LLY	$1.02T	76	10.0	10.0	4.3	6.0	—	Strong Buy
JNJ	$615.36B	57	4.7	8.5	4.3	6.0	—	Buy
ABBV	$447.53B	63	4.0	8.0	4.7	5.0	-78.83%	Buy
UNH	$391.69B	62	7.3	5.5	4.0	6.0	-30.51%	Buy
MRK	$307.25B	50	3.3	8.0	2.7	5.0	-62.28%	Hold

Smart narrative

First Tracks Biotherapeutics, Inc. Ordinary Shares When-Issued trades at $22.51. Our Smart Value Score of 23/100 indicates the stock is weak. The company scores 2/9 on the Piotroski F-Score.

Frequently asked questions

What is First Tracks Biotherapeutics, Inc. Ordinary Shares When-Issued's stock price?

First Tracks Biotherapeutics, Inc. Ordinary Shares When-Issued (TRAXV) trades at $22.51.

Is First Tracks Biotherapeutics, Inc. Ordinary Shares When-Issued overvalued?

First Tracks Biotherapeutics, Inc. Ordinary Shares When-Issued carries a Smart Value Score of 23/100 (Grade F), which we rate Strong Sell. That score blends growth, quality, and valuation into one read.

Company info

SectorHEALTHCARE

IndustryBIOTECHNOLOGY

CountryUSA

ExchangeNASDAQ

CurrencyUSD

Quick metrics

P/S ratio—

ROE-63.58%

Beta—

50D MA$21.41

200D MA$21.41

Shares out0.03B

Float—

Short ratio—

Avg volume0.0M

Performance

1 week+0.00%

1 month+0.00%

3 months+0.00%

YTD—

1 year—

3 years—

5 years—

Compare

TRAXV vs LLY →TRAXV vs JNJ →TRAXV vs ABBV →Stock screener →